LifeStance Health Group (NASDAQ:LFST) Insider Sells $368,053.20 in Stock

LifeStance Health Group, Inc. (NASDAQ:LFST) insider Lisa Miller sold 57,240 shares of the stock in a transaction on Friday, November 21st. The stock was sold at an average price of $6.43, for a total transaction of $368,053.20. Following the transaction, the insider directly owned 261,292 shares in the company, valued at $1,680,107.56. The trade was a 17.97% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

LifeStance Health Group Stock Up 2.2%

Shares of NASDAQ:LFST traded up $0.14 on Tuesday, reaching $6.63. The company had a trading volume of 1,739,211 shares, compared to its average volume of 2,007,988. The stock has a market capitalization of $2.58 billion, a P/E ratio of -221.00 and a beta of 1.16. The stock has a 50-day moving average price of $5.51 and a 200 day moving average price of $5.25. LifeStance Health Group, Inc. has a twelve month low of $3.74 and a twelve month high of $8.30. The company has a quick ratio of 1.58, a current ratio of 1.58 and a debt-to-equity ratio of 0.18.

LifeStance Health Group (NASDAQ:LFST) last issued its quarterly earnings data on Thursday, November 6th. The company reported $0.02 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.03. LifeStance Health Group had a negative return on equity of 0.62% and a negative net margin of 0.67%.The business had revenue of $363.81 million for the quarter, compared to the consensus estimate of $355.06 million. During the same period last year, the business earned ($0.02) EPS. The firm’s revenue was up 16.3% compared to the same quarter last year. LifeStance Health Group has set its Q4 2025 guidance at EPS. FY 2025 guidance at EPS. On average, equities analysts expect that LifeStance Health Group, Inc. will post -0.18 EPS for the current year.

Analysts Set New Price Targets

A number of analysts have recently weighed in on LFST shares. Wall Street Zen cut shares of LifeStance Health Group from a “buy” rating to a “hold” rating in a research note on Saturday, October 11th. Zacks Research lowered shares of LifeStance Health Group from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 5th. BTIG Research raised their price target on LifeStance Health Group from $8.00 to $9.00 and gave the company a “buy” rating in a research report on Thursday, November 6th. UBS Group boosted their price objective on LifeStance Health Group from $9.00 to $10.00 and gave the stock a “buy” rating in a research report on Friday, November 7th. Finally, BMO Capital Markets initiated coverage on LifeStance Health Group in a research note on Thursday, November 13th. They set an “outperform” rating and a $8.00 target price for the company. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $9.00.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. Bayesian Capital Management LP acquired a new stake in LifeStance Health Group during the second quarter worth about $52,000. Park Edge Advisors LLC bought a new stake in shares of LifeStance Health Group in the 2nd quarter worth approximately $52,000. Vanguard Personalized Indexing Management LLC acquired a new stake in shares of LifeStance Health Group during the 3rd quarter worth approximately $72,000. Blair William & Co. IL bought a new stake in shares of LifeStance Health Group during the second quarter valued at approximately $70,000. Finally, Public Employees Retirement System of Ohio bought a new stake in shares of LifeStance Health Group during the second quarter valued at approximately $70,000. Institutional investors and hedge funds own 85.50% of the company’s stock.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.